Ọgwụgwọ anya nkụ nke mbụ site na teknụzụ nanomicellar

Sun Pharma Canada Inc. taa kwuputara mmalite nke CEQUA, ọgwụgwọ ọhụrụ maka ndị Canada na-arịa ọrịa anya nkụ. CEQUA (cyclosporine ophthalmic solution 0.09% w / v), calcineurin inhibitor immunomodulator, bụ ọgwụgwọ anya akọrọ nke mbụ dị na Canada nke a na-enye ya na teknụzụ nanomicellar (NCELL), nke na-eme ka bioavailability na nkwụsi ike physicochemical nke cyclosporine iji mee ka ntinye anụ ahụ dịkwuo elu. .    

Print Friendly, PDF & Email

"Anyị nwere obi ụtọ iwebata CEQUA dị ka nhọrọ ọgwụgwọ ọhụrụ maka ihe karịrị nde isii ndị Canada na-arịa ọrịa anya nkụ1," Abhay Gandhi, CEO North America, Sun Pharma kwuru. "Mwepụta a bụ ihe dị mkpa maka Sun Pharma ka anyị na-agbasa Pọtụfoliyo anya anyị na Canada na ọ na-egosipụta nkwa anyị ịnye ọgwụ ọhụrụ iji kwado nhọrọ onye ọrịa na dọkịta."

Na mgbakwunye na mgbasawanye ya na mbụ n'etiti ndị Canada, akụkọ na nso nso a sitere na Center for Ocular Research & Education (CORE) egosila na ọnụ ọgụgụ nke ọrịa anya nkụ na-arị elu n'ihi mmụba nke mkpuchi mkpuchi, nke nwere ike iduga nkụ na nkụ. elu anya.2

"Anyị nwere obi ụtọ ịhụ ngwaahịa ọhụrụ dị ugbu a maka ọtụtụ ndị Canada na-arịa keratoconjunctivitis sicca ma ọ bụ ọrịa anya akọrọ," W. Bruce Jackson, MD, onye bụbu Prọfesọ na oche, Ngalaba Ophthalmology, Mahadum McGill na Mahadum Ottawa kwuru. "CEQUA, ya na teknụzụ nanomicellar ya na ike dịwanye elu nke cyclosporine, nwere ike ịbụ ihe mgbakwunye dị mkpa na nhọrọ ọgwụgwọ anyị ka ndị ọkachamara na-ahụ maka anya na-agbalịsi ike maka ọgwụgwọ ahaziri iche."

 

Print Friendly, PDF & Email

Akụkọ ndi ozo

Banyere chepụtara

nchịkọta akụkọ

Onye nchịkọta akụkọ nke eTurboNew bụ Linda Hohnholz. Ọ dabere na eTN HQ na Honolulu, Hawaii.

Ahapụ a Comment